Cargando…

The State of Patient-Reported Outcome Measures for Pediatric Patients with Inherited Retinal Disease

Patient-reported outcome measures (PROMs) are questionnaires that assess health outcomes meaningful to the patient. PROMs have multiple applications, such as supporting clinicians’ decision-making for patient care, understanding the impact of disease on patient functioning, and evaluating the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvan, Kavin, Abalem, Maria F., Lacy, Gabrielle D., Vincent, Ajoy, Héon, Elise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114271/
https://www.ncbi.nlm.nih.gov/pubmed/35499804
http://dx.doi.org/10.1007/s40123-022-00514-x
Descripción
Sumario:Patient-reported outcome measures (PROMs) are questionnaires that assess health outcomes meaningful to the patient. PROMs have multiple applications, such as supporting clinicians’ decision-making for patient care, understanding the impact of disease on patient functioning, and evaluating the efficacy of therapeutics. Though PROMs were developed for various eye conditions, no PROM was tailored to pediatric patients with inherited retinal disease (IRD). Hence, a literature search was conducted using MEDLINE and Embase to identify PROMs potentially relevant to this patient population. This review evaluated selected pediatric PROMs against the US Food and Drug Administration (FDA) guidelines and found restricted use in the context of IRD. As there is a need for PROMs tailored to pediatric patients with IRD, we provide a perspective on applying the International Society for Pharmacoeconomics and Outcomes Research and FDA standards on the development of PROMs specific to IRD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40123-022-00514-x.